510(k) K203530
K203530 is an FDA 510(k) premarket notification submitted by Abbott Ireland Diagnostics Division for the device "Albumin BCP2". The FDA issued a decision of Substantially Equivalent on Mar 18, 2022. The device falls under product code CJW (Bromcresol Purple Dye-Binding, Albumin), a Class II device regulated under 21 CFR 862.1035. Abbott Ireland Diagnostics Division has 7 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Mar 18, 2022
- Date Received
- Dec 2, 2020
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Bromcresol Purple Dye-Binding, Albumin
- Device Class
- Class II
- Regulation Number
- 862.1035
- Review Panel
- CH
- Submission Type
- 510(k)
Need the full FDA record for Abbott Ireland Diagnostics Division? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.